Prognosis of surgically treated primary parotid gland cancer - An evaluation of 231 cases;Zur Prognose chirurgisch therapierter primärer Parotiskarzinome - Eine Untersuchung an 231 Fällen

Laryngo- Rhino- Otologie

Volumn 90, Issue 11, 2011, Pages 664-671

  Stenner, M ^a   Molls, C ^a   Klumann, J P ^b   Httenbrink, K B ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

follow up; parotid gland carcinoma; prognosis; salivary gland cancer; survival

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FACIAL NERVE PARALYSIS; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PAROTID GLAND CANCER; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAROTID GLAND; PAROTID NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 81555199964     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0031-1285924     Document Type: Article

References (28)

1. Vander Poorten V L. Salivary gland carcinoma stepping up the prognostic ladder. Amsterdam, The Netherlands University of Amsterdam: 2002; 222
2. Boukheris H, Curtis R E, Land C E, Dores G M. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev: 2009; 18 2899 2906
3. Barnes L, Eveson J W, Reichart P, Sidransky D. Tumours of the salivary gland. InPathology and genetics. Head and neck tumours. World Health Organization Classification of Tumours. vol. 9 Lyon, France IARC Press: 2005; 209 281
4. Kokemueller H, Swennen G, Brueggemann N, Brachvogel P, Eckardt A, Hausamen J E. Epithelial malignancies of the salivary glands: clinical experience of a single institution a review. Int J Oral Maxillofac Surg: 2004; 33 423 432 (Pubitemid 38950208)
5. Platzer W, Maurer H, Thumfart W F, Gunkel A R. Surgical techniques: parotid region. I. Laryngorhinootol: 2007; 86 467 473
6. Nagliati M, Bolner A, Vanoni V, Tomio L, Lay G, Murtas R, Deidda M A, Madeddu A, Delmastro E, Verna R, Gabriele P, Amichetti M. Surgery and radiotherapy in the treatment of malignant parotid tumors: a retrospective multicenter study. Tumori: 2009; 95 442 448
7. Hamakawa H, Nakashiro K, Sumida T, Shintani S, Myers J N, Takes R P, Rinaldo A, Ferlito A. Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck: 2008; 30 800 809 (Pubitemid 351913858)
8. Laurie S A, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol: 2006; 24 2673 2678 (Pubitemid 46622089)
9. Poorten V V, Hart A, Vauterin T, Jeunen G, Schoenaers J, Hamoir M, Balm A, Stennert E, Guntinas-Lichius O, Delaere P. Prognostic index for patients with parotid carcinoma: international external validation in a Belgian-German database. Cancer: 2009; 115 540 550
10. Stenner M, Klussmann J P. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. Eur Arch Otorhinolaryngol: 2009; 266 333 341
11. Stenner M, Weinell A, Ponert T, Hardt A, Hahn M, Preuss S F, Guntinas-Lichius O, Klussmann J P. Cytoplasmic expression of survivin is an independent predictor of poor prognosis in patients with salivary gland cancer. Histopathology: 2010; 57 699 706
12. Stenner M, Demgensky A, Molls C, Hardt A, Luers J C, Grosheva M, Huebbers C U, Klussmann J P. Prognostic value of survivin expression in parotid gland cancer in consideration of different histological subtypes. Eur J Cancer: 2011; 47 1013 1020
13. Hickman R E, Cawson R A, Duffy S W. The prognosis of specific types of salivary gland tumors. Cancer: 1984; 54 1620 1624 (Pubitemid 14006225)
14. Lang S, Rotter N, Lorenzen A, Ihrler S, Eckel R, Holzel D, Rasp G, Wollenberg B, Sommer K. Salivary gland carcinomas. 1. Epidemiology, etiology, malignancy criteria, prognostic parameters and classification. HNO: 2005; 53 817 826
15. Hocwald E, Korkmaz H, Yoo G H, Adsay V, Shibuya T Y, Abrams J, Jacobs J R. Prognostic factors in major salivary gland cancer. Laryngoscope: 2001; 111 1434 1439 (Pubitemid 32730192)
16. UICC TNM classification of malignant tumours. John Wiley & Sons: 2002
17. Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, Makitie A, Virtaniemi J, Hinkka S, Grenman R. Salivary gland cancer in Finland 199196: an evaluation of 237 cases. Acta Otolaryngol: 2005; 125 207 214 (Pubitemid 40293215)
18. Stennert E, Kisner D, Jungehuelsing M, Guntinas-Lichius O, Schroder U, Eckel H E, Klussmann J P. High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg: 2003; 129 720 723 (Pubitemid 36858957)
19. Takahama J A, Almeida O P, Kowalski L P. Parotid neoplasms: analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol: 2009; 75 497 501
20. Terhaard C H, Lubsen H, Van dT I, Hilgers F J, Eijkenboom W M, Marres H A, Tjho-Heslinga R E, de Jong J M, Roodenburg J L. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck: 2004; 26 681 692 (Pubitemid 39014632)
21. Klussmann J P, Ponert T, Mueller R P, Dienes H P, Guntinas-Lichius O. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur J Surg Oncol: 2008; 34 932 937
22. Carrillo J F, Vazquez R, Ramirez-Ortega M C, Cano A, Ochoa-Carrillo F J, Onate-Ocana L F. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer: 2007; 109 2043 2051 (Pubitemid 46744199)
23. Stennert E, Wittekindt C, Klussmann J P, Guntinas-Lichius O. New aspects in parotid gland surgery. Otolaryngol Pol: 2004; 58 109 114
24. Zbaren P, Schupbach J, Nuyens M, Stauffer E, Greiner R, Hausler R. Carcinoma of the parotid gland. Am J Surg: 2003; 186 57 62 (Pubitemid 36774001)
25. Zbaren P, Schupbach J, Nuyens M, Stauffer E. Elective neck dissection versus observation in primary parotid carcinoma. Otolaryngol Head Neck Surg: 2005; 132 387 391 (Pubitemid 40326687)
26. Valstar M H, van den Brekel M W, Smeele L E. Interpretation of treatment outcome in the clinically node-negative neck in primary parotid carcinoma: a systematic review of the literature. Head Neck: 2010; 32 1402 1411
27. Noh J M, Ahn Y C, Nam H, Park W, Baek C H, Son Y I, Jeong H S. Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy. Clin Exp Otorhinolaryngol: 2010; 3 96 101
28. Stenner M, Molls C, Luers J C, Beutner D, Klussmann J P, Huettenbrink K B. Occurrence of lymph node metastasis in early-stage parotid gland cancer. Eur Arch Otorhinolaryngol: 2011; Epub ahead of print